Related Experiment Video
Updated: Jul 23, 2026

10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
Assessing whether a clinical pharmacy program is meeting its goals
Summary
The clinical pharmacy program at Memorial Hospital Medical Center successfully met its goals, enhancing patient care quality through pharmacist interventions and drug monitoring. This study highlights the valuable role of clinical pharmacists in healthcare.
Area of Science:
- Health Sciences
- Pharmacy Practice
- Hospital Administration
Background:
- Memorial Hospital Medical Center (MHMC) established a clinical pharmacy program in 1967.
- The program aimed to standardize clinical services, integrate pharmacists with physicians and nurses, and ensure high-quality patient care.
Purpose of the Study:
- To assess the effectiveness and goal attainment of MHMC's clinical pharmacy program.
- To evaluate the impact of clinical pharmacists on patient care quality and interprofessional collaboration.
Main Methods:
- Data collection over six weeks via surveys (pharmacists, physicians, nurses), service reports, medical record audits, guideline compliance checks, interviews, and encounter logs.
- Quantitative analysis of drug monitoring, audits, and pharmacist-provider interactions.
Main Results:
- The clinical pharmacy program generally met its objectives.
- Pharmacist-initiated drug monitoring led to therapy changes in 20% of cases.
- High satisfaction (99-100%) reported for drug information services.
- Physicians (96%) and nurses (97%) perceived improved patient care due to pharmacist involvement.
Conclusions:
- MHMC's clinical pharmacy program is effectively meeting its goals.
- Clinical pharmacists play a vital role in improving patient care quality and collaborating with healthcare providers.
- The program demonstrates successful integration and positive impact within a large teaching hospital setting.
Related Concept Videos
Nursing Evaluation
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Section...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

